Global Dermatophytosis Therapeutics Market Research Report 2023

Report ID: 1897803 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Dermatophytosis Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Rx
        1.2.3 OTC
    1.3 Market by Application
        1.3.1 Global Dermatophytosis Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Dermatophytosis Therapeutics Market Perspective (2017-2028)
    2.2 Dermatophytosis Therapeutics Growth Trends by Region
        2.2.1 Dermatophytosis Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Dermatophytosis Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Dermatophytosis Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Dermatophytosis Therapeutics Market Dynamics
        2.3.1 Dermatophytosis Therapeutics Industry Trends
        2.3.2 Dermatophytosis Therapeutics Market Drivers
        2.3.3 Dermatophytosis Therapeutics Market Challenges
        2.3.4 Dermatophytosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Dermatophytosis Therapeutics Players by Revenue
        3.1.1 Global Top Dermatophytosis Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Dermatophytosis Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Dermatophytosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Dermatophytosis Therapeutics Revenue
    3.4 Global Dermatophytosis Therapeutics Market Concentration Ratio
        3.4.1 Global Dermatophytosis Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Dermatophytosis Therapeutics Revenue in 2021
    3.5 Dermatophytosis Therapeutics Key Players Head office and Area Served
    3.6 Key Players Dermatophytosis Therapeutics Product Solution and Service
    3.7 Date of Enter into Dermatophytosis Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatophytosis Therapeutics Breakdown Data by Type
    4.1 Global Dermatophytosis Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Dermatophytosis Therapeutics Forecasted Market Size by Type (2023-2028)
5 Dermatophytosis Therapeutics Breakdown Data by Application
    5.1 Global Dermatophytosis Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Dermatophytosis Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Dermatophytosis Therapeutics Market Size (2017-2028)
    6.2 North America Dermatophytosis Therapeutics Market Size by Country (2017-2022)
    6.3 North America Dermatophytosis Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Dermatophytosis Therapeutics Market Size (2017-2028)
    7.2 Europe Dermatophytosis Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Dermatophytosis Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Dermatophytosis Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Dermatophytosis Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Dermatophytosis Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Dermatophytosis Therapeutics Market Size (2017-2028)
    9.2 Latin America Dermatophytosis Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Dermatophytosis Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Dermatophytosis Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Dermatophytosis Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Dermatophytosis Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Novartis
        11.1.1 Novartis Company Detail
        11.1.2 Novartis Business Overview
        11.1.3 Novartis Dermatophytosis Therapeutics Introduction
        11.1.4 Novartis Revenue in Dermatophytosis Therapeutics Business (2017-2022)
        11.1.5 Novartis Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Dermatophytosis Therapeutics Introduction
        11.2.4 Pfizer Revenue in Dermatophytosis Therapeutics Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Sanofi-Aventis
        11.3.1 Sanofi-Aventis Company Detail
        11.3.2 Sanofi-Aventis Business Overview
        11.3.3 Sanofi-Aventis Dermatophytosis Therapeutics Introduction
        11.3.4 Sanofi-Aventis Revenue in Dermatophytosis Therapeutics Business (2017-2022)
        11.3.5 Sanofi-Aventis Recent Development
    11.4 Merck
        11.4.1 Merck Company Detail
        11.4.2 Merck Business Overview
        11.4.3 Merck Dermatophytosis Therapeutics Introduction
        11.4.4 Merck Revenue in Dermatophytosis Therapeutics Business (2017-2022)
        11.4.5 Merck Recent Development
    11.5 Enzon Pharmaceuticals
        11.5.1 Enzon Pharmaceuticals Company Detail
        11.5.2 Enzon Pharmaceuticals Business Overview
        11.5.3 Enzon Pharmaceuticals Dermatophytosis Therapeutics Introduction
        11.5.4 Enzon Pharmaceuticals Revenue in Dermatophytosis Therapeutics Business (2017-2022)
        11.5.5 Enzon Pharmaceuticals Recent Development
    11.6 Bayer
        11.6.1 Bayer Company Detail
        11.6.2 Bayer Business Overview
        11.6.3 Bayer Dermatophytosis Therapeutics Introduction
        11.6.4 Bayer Revenue in Dermatophytosis Therapeutics Business (2017-2022)
        11.6.5 Bayer Recent Development
    11.7 Astellas Pharma
        11.7.1 Astellas Pharma Company Detail
        11.7.2 Astellas Pharma Business Overview
        11.7.3 Astellas Pharma Dermatophytosis Therapeutics Introduction
        11.7.4 Astellas Pharma Revenue in Dermatophytosis Therapeutics Business (2017-2022)
        11.7.5 Astellas Pharma Recent Development
    11.8 GSK
        11.8.1 GSK Company Detail
        11.8.2 GSK Business Overview
        11.8.3 GSK Dermatophytosis Therapeutics Introduction
        11.8.4 GSK Revenue in Dermatophytosis Therapeutics Business (2017-2022)
        11.8.5 GSK Recent Development
    11.9 Abbott
        11.9.1 Abbott Company Detail
        11.9.2 Abbott Business Overview
        11.9.3 Abbott Dermatophytosis Therapeutics Introduction
        11.9.4 Abbott Revenue in Dermatophytosis Therapeutics Business (2017-2022)
        11.9.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Dermatophytosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Rx
    Table 3. Key Players of OTC
    Table 4. Global Dermatophytosis Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Dermatophytosis Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Dermatophytosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Dermatophytosis Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Dermatophytosis Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Dermatophytosis Therapeutics Market Share by Region (2023-2028)
    Table 10. Dermatophytosis Therapeutics Market Trends
    Table 11. Dermatophytosis Therapeutics Market Drivers
    Table 12. Dermatophytosis Therapeutics Market Challenges
    Table 13. Dermatophytosis Therapeutics Market Restraints
    Table 14. Global Dermatophytosis Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Dermatophytosis Therapeutics Market Share by Players (2017-2022)
    Table 16. Global Top Dermatophytosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatophytosis Therapeutics as of 2021)
    Table 17. Ranking of Global Top Dermatophytosis Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Dermatophytosis Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Dermatophytosis Therapeutics Product Solution and Service
    Table 21. Date of Enter into Dermatophytosis Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Dermatophytosis Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Dermatophytosis Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Dermatophytosis Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Dermatophytosis Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Dermatophytosis Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Dermatophytosis Therapeutics Revenue Market Share by Application (2017-2022)
    Table 29. Global Dermatophytosis Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Dermatophytosis Therapeutics Revenue Market Share by Application (2023-2028)
    Table 31. North America Dermatophytosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Dermatophytosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Dermatophytosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Dermatophytosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Dermatophytosis Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Dermatophytosis Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Dermatophytosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Dermatophytosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Dermatophytosis Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Dermatophytosis Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Novartis Company Detail
    Table 42. Novartis Business Overview
    Table 43. Novartis Dermatophytosis Therapeutics Product
    Table 44. Novartis Revenue in Dermatophytosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 45. Novartis Recent Development
    Table 46. Pfizer Company Detail
    Table 47. Pfizer Business Overview
    Table 48. Pfizer Dermatophytosis Therapeutics Product
    Table 49. Pfizer Revenue in Dermatophytosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 50. Pfizer Recent Development
    Table 51. Sanofi-Aventis Company Detail
    Table 52. Sanofi-Aventis Business Overview
    Table 53. Sanofi-Aventis Dermatophytosis Therapeutics Product
    Table 54. Sanofi-Aventis Revenue in Dermatophytosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 55. Sanofi-Aventis Recent Development
    Table 56. Merck Company Detail
    Table 57. Merck Business Overview
    Table 58. Merck Dermatophytosis Therapeutics Product
    Table 59. Merck Revenue in Dermatophytosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 60. Merck Recent Development
    Table 61. Enzon Pharmaceuticals Company Detail
    Table 62. Enzon Pharmaceuticals Business Overview
    Table 63. Enzon Pharmaceuticals Dermatophytosis Therapeutics Product
    Table 64. Enzon Pharmaceuticals Revenue in Dermatophytosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Enzon Pharmaceuticals Recent Development
    Table 66. Bayer Company Detail
    Table 67. Bayer Business Overview
    Table 68. Bayer Dermatophytosis Therapeutics Product
    Table 69. Bayer Revenue in Dermatophytosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Bayer Recent Development
    Table 71. Astellas Pharma Company Detail
    Table 72. Astellas Pharma Business Overview
    Table 73. Astellas Pharma Dermatophytosis Therapeutics Product
    Table 74. Astellas Pharma Revenue in Dermatophytosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. Astellas Pharma Recent Development
    Table 76. GSK Company Detail
    Table 77. GSK Business Overview
    Table 78. GSK Dermatophytosis Therapeutics Product
    Table 79. GSK Revenue in Dermatophytosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. GSK Recent Development
    Table 81. Abbott Company Detail
    Table 82. Abbott Business Overview
    Table 83. Abbott Dermatophytosis Therapeutics Product
    Table 84. Abbott Revenue in Dermatophytosis Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. Abbott Recent Development
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dermatophytosis Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Rx Features
    Figure 3. OTC Features
    Figure 4. Global Dermatophytosis Therapeutics Market Share by Application in 2021 & 2028
    Figure 5. Hospital Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Other Case Studies
    Figure 8. Dermatophytosis Therapeutics Report Years Considered
    Figure 9. Global Dermatophytosis Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Dermatophytosis Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Dermatophytosis Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Dermatophytosis Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Dermatophytosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatophytosis Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Dermatophytosis Therapeutics Revenue in 2021
    Figure 15. North America Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Dermatophytosis Therapeutics Market Share by Country (2017-2028)
    Figure 17. United States Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Dermatophytosis Therapeutics Market Share by Country (2017-2028)
    Figure 21. Germany Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Dermatophytosis Therapeutics Market Share by Region (2017-2028)
    Figure 29. China Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Dermatophytosis Therapeutics Market Share by Country (2017-2028)
    Figure 37. Mexico Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Dermatophytosis Therapeutics Market Share by Country (2017-2028)
    Figure 41. Turkey Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Dermatophytosis Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Novartis Revenue Growth Rate in Dermatophytosis Therapeutics Business (2017-2022)
    Figure 44. Pfizer Revenue Growth Rate in Dermatophytosis Therapeutics Business (2017-2022)
    Figure 45. Sanofi-Aventis Revenue Growth Rate in Dermatophytosis Therapeutics Business (2017-2022)
    Figure 46. Merck Revenue Growth Rate in Dermatophytosis Therapeutics Business (2017-2022)
    Figure 47. Enzon Pharmaceuticals Revenue Growth Rate in Dermatophytosis Therapeutics Business (2017-2022)
    Figure 48. Bayer Revenue Growth Rate in Dermatophytosis Therapeutics Business (2017-2022)
    Figure 49. Astellas Pharma Revenue Growth Rate in Dermatophytosis Therapeutics Business (2017-2022)
    Figure 50. GSK Revenue Growth Rate in Dermatophytosis Therapeutics Business (2017-2022)
    Figure 51. Abbott Revenue Growth Rate in Dermatophytosis Therapeutics Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Pfizer
Sanofi-Aventis
Merck
Enzon Pharmaceuticals
Bayer
Astellas Pharma
GSK
Abbott
Frequently Asked Questions
Dermatophytosis Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dermatophytosis Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dermatophytosis Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Diabetic Pen Cap

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Insulin Pen Cap

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More